Crescent Capital III is a venture capital fund part funded by the European Regional Development Fund under the EU Investment for Growth and Jobs Programme 2014-2020 – Crescent Capital III
FIND OUT MORE

News from Crescent and our Investees

Speechstorm Webinar with Ovum showcases innovative product line

Speechstorm Webinar with Ovum showcases innovative product line

This webinar and slidepack on ” Making Automatioc Feel Less Automated and More Caring,” is a good introduction to... Find Out More
PathXL provides Oxford Biomedical Research Centre with Integrated Digital Pathology Solution

PathXL provides Oxford Biomedical Research Centre with Integrated Digital Pathology Solution

“Flexibility, speed and objectivity” are the key benefits that PathXL’s Integrated Digital Pathology Solution is providing to the Oxford... Find Out More

CSR aptX Codec Gives Samsung GALAXY Tab 7.0 Plus Superior Wireless Audio

Published November 2011 As part of an ongoing licensing partnership with Samsung Electronics, CSR Plc (LSE: CSR and NASDAQ:... Find Out More
Speechstorm’s intern wins Group Best Mobile Application 2011

Speechstorm’s intern wins Group Best Mobile Application 2011

Published 7th November 2011 Speechstorm a leader in software for automating customer service over the phone, is pleased to... Find Out More
Xilinx comes to OFC with a design platform – and an Omiino acquisition

Xilinx comes to OFC with a design platform – and an Omiino acquisition

Published March 2011 The Optical Fibers in Communications Conference opens 7th March 2011 in Los Angeles, and Xilinx Inc.... Find Out More

i-Path secures NI Biobank contract

A collaboration between Queen’s University Belfast, the Belfast Health and Social Care Trust (BHSCT) and the University of Ulster... Find Out More